Therefore, compounds that targeting Bach1 to alleviate oxidative damage and inflammatory response are thought to possess therapeutic effects on periodontitis and other inflammatory diseases.39 However, there is not one clinical drug targeting Bach1 and only pre-clinical research about inhibitors of Bach1 is conducted. Here, BACH1 is linked to periodontitis.